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Antibiotic resistance
Global warming tops the list of the present hotly debated global 
topics. Another man-made disaster, which has been lurking 
under the radar as far as the public is concerned, is antibiotic 
resistance. Think of the consequences of the emergence of 
multi-drug-resistant TB! In a further timely reminder Brink 
and colleagues report on the antimicrobial susceptibility profile 
of selected bacteraemic pathogens from private institutions 
in South Africa (p. 273), and this is reinforced by an editorial 
by Jan van den Ende (p. 264). They forcefully underline the 
unwelcome capacity of bacteria to keep ahead of our efforts in 
the resistance race.
The study included only selected bacteria, including 
Escherichia coli, Klebsiella pneumoniae, Enterobacter species, 
Pseudomonas aeruginosa, Actinobacter baumanii and Staphylococcus 
aureus. These were chosen because they represent the most 
common hospital-acquired pathogens and those in which 
antibiotic resistance is a recognised problem. 
The main and important messages that come from this 
study are the high levels of resistance to key ‘workhorse’ 
antibiotics used in hospitals, the identification of significant 
prevalences of extended-spectrum β-lactamases and other 
resistance mechanisms in the Enterobacteriaceae studied, and 
considerable differences in resistance prevalences between 
centres. Bacterial resistance to antimicrobial agents, both in 
community and health care settings, has long been recognised 
as a worldwide phenomenon of increasing extent and 
relevance. Acquired resistance (resistance emerging in bacterial 
species formerly sensitive to the particular agent/s) is also 
recognised as a consequence of selective pressure in the form of 
antibiotic usage. 
Multiple resistance seriously limits the range of antimicrobial 
agents available for treatment of infections. In hospital-acquired 
infections, inappropriate initial antimicrobial therapy is an 
important determinant of morbidity and mortality. Initial 
empirical choice is best guided by contemporary susceptibility 
data at institutional or preferably service and unit (e.g. 
intensive care unit) level. Exposing the problem of antibiotic 
resistance underpins the promotion of more effective and 
judicious use of antibiotics in private hospitals – to which we 
can add all settings.
Peripheral arterial disease in rural 
black South Africans
Anecdotal experience of a high prevalence of peripheral arte-
rial disease (PAD) in rural blacks by practitioners who have 
performed large numbers of amputations for gangrenous limbs 
is confirmed by a study by Kumar et al. (p. 285). 
Most clinicians diagnose PAD from symptoms such as 
intermittent claudication and rest pain, and signs such as 
diminished peripheral pulses, ischaemic ulceration and 
gangrene, but these are not always reliable and physician 
awareness of the diagnosis is low. In most cases PAD can be 
confirmed by measuring the ankle-brachial pressure index 
(ABPI), often by Doppler ultrasound.  An ABPI of less than 0.9 
is diagnostic of PAD. 
The validity of ABPI as a diagnostic marker of subclinical 
arterial disease is confirmed by its adverse prognostic 
significance for coronary and cerebrovascular events. The 
29% prevalence in the over-50-year-old rural black population 
studied was at the upper end of rates reported internationally. 
The association of PAD in this study with male sex, diabetes 
and smoking was not surprising.
Angio-oedema and ACE inhibitor use
A diagnosis of death due to angio-oedema associated with 
enalapril prompted a review of the records of all admissions to 
the ICUs in the UCT academic region. Clint Cupido and Brian 
Rayner uncovered a further 9 cases of angio-oedema requiring 
intubation related to enalapril (p. 244).  
Although angio-oedema is a well-recognised complication 
of angiotensin-converting enzyme (ACE) inhibitor use, only 
isolated reports of death have appeared in the literature. 
Increased risk for angio-oedema was found in blacks, patients 
with a history of drug rash or seasonal allergy, and patients 
over the age of 65 years. Most cases occurred during the first 
months of therapy, but it may occur more than 10 years after 
initiation of treatment. The authors consider it unfortunate that 
angio-oedema is not listed as a compelling contraindication 
to ACE inhibitors in the latest South African Hypertension 
Guidelines.
Steroids and antihistamines are ineffective as the mechanism 
of the reaction is not allergic but related to bradykinin. 
Adrenaline may be helpful, but if there is a suspicion of 
airway compromise endotracheal intubation should be 
performed immediately and if unsuccessful an emergency 
cricothyroidotomy or tracheostomy should be performed.
Early black doctors in South Africa
The first of a historical series on black doctors by Anne Digby 
appears in this issue of the SAMJ (p. 252). Dan Ncayiyana (p. 
219) adds a fascinating personal glimpse into the times and the 
practice of Dr James Moroka, an iconic political leader and rural 
general practitioner. 
The importance of the Scottish influence on education and 
medicine is evident in these studies. Dr Moroka’s story is 
typical of the early black doctors, who all qualified abroad 
because of lack of training opportunities here at home. They 
returned home into leadership positions and had to wrestle 
with the choice between political activism and their medical 
careers. The latter also applies to many more recently qualified 
black doctors, whether qualified locally or overseas, who have 
played a leading role in the democratisation of South Africa.
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